Filing Details

Accession Number:
0001104659-21-116452
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-16 17:18:37
Reporting Period:
2021-09-14
Accepted Time:
2021-09-16 17:18:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1851182 Future Health Esg Corp. FHLT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1812107 Bradley Bostic C/O Future Health Esg Corp.
8 The Green, Suite #12081
Dover DE 19901
Ceo And Secretary Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Disposition 2021-09-14 614,899 $0.01 103,851 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
See Footnote Warrant Acquisiton 2021-09-14 713,056 $1.00 0 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
713,056 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share 562,781 Indirect See Footnote
Common Stock, Par Value $0.0001 Per Share 11,385 Indirect See Footnote
Common Stock, Par Value $0.0001 Per Share 337,653 Indirect See Footnote
Footnotes
  1. Represents shares transferred by MB Equity, LLC to anchor investors in connection with the Issuer's initial public offering at the same price per share as MB Equity, LLC initially paid for such shares.
  2. Includes up to 13,546 shares subject to forfeiture by MB Equity, LLC if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
  3. The shares are held directly by MB Equity, LLC. The Reporting Person disclaims beneficial ownership of the securities held by MB Equity, LLC other than the reported securities except to the extent of his pecuniary interest therein.
  4. Includes up to 73,406 shares subject to forfeiture by BEA Holdings, LLC if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
  5. The shares are held directly by BEA Holdings, LLC, of which the Reporting Person is the sole manager.
  6. Includes up to 1,485 shares subject to forfeiture by hc1.com, Inc. if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
  7. The shares are held directly by hc1.com, Inc., of which the Reporting Person is the Chief Executive Officer and Chairman. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The Reporting Person disclaims beneficial ownership of the securities held by hc1.com, Inc. other than the reported securities except to the extent of his pecuniary interest therein.
  8. Includes up to 44,042 shares subject to forfeiture by Future Health ESG Associates 1, LLC if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
  9. The securities are held directly by Future Health ESG Associates 1, LLC, of which the Reporting Person is a manager, and indirectly by b2 Holdings, LLC, of which the Reporting Person is the manager, BEA Holdings, LLC, and three individual retirement accounts in the names of two of the Reporting Person's daughters and the Reporting Person's son, respectively. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The Reporting Person disclaims beneficial ownership of the securities held by Future Health ESG Associates 1, LLC other than the reported securities except to the extent of his pecuniary interest therein.
  10. Each warrant will become exercisable 30 days after the completion of the Issuer's initial business combination. Each warrant will expire five years after the completion of the Issuer's initial business combination. Each warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment in the event of certain capital-raising or reorganization transactions.